Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine

Detailed price information for Vera Therapeutics Inc Cl A (VERA-Q) from The Globe and Mail including charting and trades.
The Island

Continuing as an Advisor to the Government on Productivity Promotion

SYNTHESISING MANAGEMENT THEORY WITH PRACTICE – PART 27 Connecting with the previous episode In the previous article I ...

8th Pay Commission: Explained How A Stronger Fitment Factor Could Fuel Stock Market Growth

A higher fitment factor directly results in a more substantial salary and pension jump for over one crore government ...
The IslandOpinion

Making myself heard in Parliament and NGO role in peace process

The main manner of communication in Parliament is through speeches delivered in the House on Government business and the ...

Explained: How CBSE’s new skill based learning framework will reshape classes 6 to 8

CBSE mandates skill education for Classes 6-8 from 2025-26, integrating hands-on learning in three work domains. This reform aims to reduce rote learning and expose students to real-life skills, but ...